Sign in

CIK 0001521036 · Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
352318913
Phone
978 671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 8-K Event Other events
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 8-K Event Other events
  7. 8-K Event Shareholder vote results
  8. DEFA14A Proxy Proxy Materials
  9. 8-K Event Other events
  10. SCHEDULE 13D/A Stake Beneficial Ownership Report
  11. DEFA14A Proxy Proxy Materials
  12. 8-K Event Other events
  13. DEFA14A Proxy Proxy Materials
  14. 4 Open-market sale 10% owner sold 247,932 shares at an average $3.13 ($776,947)
  15. DEFM14A Deal DEFM14A
  16. 4 Open-market sale 10% owner sold 42,129 shares at $3.11 ($131,219)
  17. SCHEDULE 13D/A Stake Beneficial Ownership Report
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. SCHEDULE 13D Stake Beneficial Ownership Report
  20. 4 Open-market sale 10% owner sold 35,769 shares at $3.12 ($111,574)

Page 1 of 57 · 1,121 filings